Dosing-Time contributes to chronotoxicity of clofarabine in mice via means other than pharmacokinetics

Citations of this article
Mendeley users who have this article in their library.


To evaluate the time-And dose-dependent toxicity of clofarabine in mice and to further define the chronotherapy strategy of it in leukemia, we compared the mortality rates, LD50s, biochemical parameters, histological changes and organ indexes of mice treated with clofarabine at various doses and time points. Plasma clofarabine levels and pharmacokinetic parameters were monitored continuously for up to 8 hours after the single intravenous administration of 20 mg/kg at 12:00 noon and 12:00 midnight by high performance liquid chromatography (HPLC)-UV method. Clofarabine toxicity in all groups fluctuated in accordance with circadian rhythms in vivo. The toxicity of clofarabine in mice in the rest phase was more severe than the active one, indicated by more severe liver damage, immunodepression, higher mortality rate, and lower LD50. No significant pharmacokinetic parameter changes were observed between the night and daytime treatment groups. These findings suggest the dosing-Time dependent toxicity of clofarabine synchronizes with the circadian rhythm of mice, which might provide new therapeutic strategies in further clinical application.




Luan, J. J., Zhang, Y. S., Liu, X. Y., Wang, Y. Q., Zuo, J., Song, J. G., … Wang, W. S. (2016). Dosing-Time contributes to chronotoxicity of clofarabine in mice via means other than pharmacokinetics. Kaohsiung Journal of Medical Sciences, 32(5), 227–234.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free